Baylor Health Care System/Sammons Cancer Center Baylor- Sammons — Dallas, Texas

Baylor Health Care System/Sammons Cancer Center Baylor- Sammons is a clinical research site located in Dallas, Texas, United States 75246.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Baylor Health Care System/Sammons Cancer Center Baylor- Sammons has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer, Advanced Solid Tumors, Cowden Syndrome.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Baylor Health Care System/Sammons Cancer Center Baylor- Sammons?

Baylor Health Care System/Sammons Cancer Center Baylor- Sammons has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Baylor Health Care System/Sammons Cancer Center Baylor- Sammons conducted?

Baylor Health Care System/Sammons Cancer Center Baylor- Sammons has 1 clinical trials on record. Their work covers Breast Cancer, Advanced Solid Tumors, Cowden Syndrome.

Is Baylor Health Care System/Sammons Cancer Center Baylor- Sammons accredited by Crixeo Clinical Trials?

Baylor Health Care System/Sammons Cancer Center Baylor- Sammons has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Baylor Health Care System/Sammons Cancer Center Baylor- Sammons?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.